This inventor holds 1 USPTO granted patent. Top assignee: Arcturus Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Rajesh Mukthavaram: Innovator in Nucleic Acid Delivery
Introduction
Rajesh Mukthavaram is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work has the potential to impact immunization strategies against various diseases.
Latest Patents
Rajesh holds a patent for "Lipid particles for nucleic acid delivery." This patent describes a method for achieving nucleic acid immunization by delivering nucleic acids, such as mRNA or DNA, encapsulated within lipid-nucleic acid nanoparticles. The nanoparticles are designed for effective in vivo delivery of nucleic acids to vertebrate cells, making them a valuable tool for immunizing subjects against a range of diseases.
Career Highlights
Rajesh is currently associated with Arcturus Therapeutics, Inc., where he continues to advance his research in nucleic acid delivery systems. His work is instrumental in developing pharmaceutical compositions that utilize lipid-nucleic acid nanoparticles for immunization purposes.
Collaborations
Rajesh collaborates with talented professionals in his field, including Padmanabh Chivukula and Priya Prakash Karmali. These collaborations enhance the innovative potential of his research and contribute to the advancement of biotechnology.
Conclusion
Rajesh Mukthavaram is a key figure in the development of nucleic acid delivery systems, with a focus on improving immunization techniques. His contributions to the field are paving the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile